Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin inhibitor monotherapy versus sirolimus monotherapy after liver transplantation in hepatitis C patients with hepatic fibrosis
2008-000252-28Phase 4Terminated
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Apr 2009
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of sirolimus, tacrolimus and cyclosporine in hepatitis C virus infection and hepatic fibrosis (2 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Change in fibrosis stage over the study period. Started Apr 2009; status: terminated.
02
Drugs
sirolimustacrolimuscyclosporine
03
Conditions
hepatitis C virus infectionhepatic fibrosis
Beyond the preview
Go deeper on 2008-000252-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000252-28.